Holyrab-D Capsule SR is a combination pharmaceutical formulation containing Domperidone 30 mg and Rabeprazole 20 mg, designed for the management of gastrointestinal disorders characterized by acid-related symptoms and motility disturbances. Domperidone, a peripheral dopamine D2 receptor antagonist, facilitates gastric emptying and enhances gastrointestinal motility, thereby alleviating symptoms such as nausea, vomiting, bloating, and early satiety. Rabeprazole, a proton pump inhibitor (PPI), suppresses gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, providing effective relief from acid-related conditions including gastroesophageal reflux disease (GERD), peptic ulcers, and erosive esophagitis. The sustained-release (SR) formulation ensures prolonged therapeutic plasma concentrations, improving patient compliance and symptom control. Holyrab-D Capsule SR is indicated for patients requiring combined acid suppression and prokinetic therapy, particularly in cases where delayed gastric emptying exacerbates acid reflux symptoms. It is recommended to be taken orally as prescribed by a healthcare professional. Caution is advised in patients with known hypersensitivity to either component, cardiac arrhythmias, or severe hepatic impairment. Regular monitoring and adherence to prescribed dosage are essential to optimize therapeutic outcomes and minimize adverse effects.

Dosage & How to Use